Related Experiment Video
Updated: Jul 4, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Initiating and intensifying insulin therapy in type 2 diabetes mellitus
1Department of Endocrinology, Flushing Hospital Medical Center, Flushing, New York, USA. JTibaldi@aol.com
The American Journal of Medicine
|June 27, 2008
Summary
Insulin therapy for type 2 diabetes is manageable with modern options. Patient education and newer insulin formulations help overcome challenges like hypoglycemia and injection anxiety, making treatment effective and well-tolerated.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Background:
- Insulin therapy is crucial for managing type 2 diabetes mellitus (T2DM) progression.
- Patient and caregiver perceptions often present challenges in initiating and intensifying insulin treatment.
Purpose of the Study:
- To review challenges associated with insulin therapy in T2DM.
- To provide practical strategies for patient education and insulin regimen management.
- To address common concerns regarding insulin use in T2DM.
Main Methods:
- Literature review focusing on patient education, insulin analogues, delivery systems, and titration algorithms.
- Analysis of clinical trial data comparing insulin analogues with human insulins.
- Discussion of patient-reported outcomes and concerns.
Main Results:
- Patient education on pathophysiology and active treatment involvement can improve attitudes towards insulin.
- Insulin analogues offer more physiologic profiles and convenience, potentially reducing hypoglycemia risk.
- Modern insulin delivery systems and titration algorithms simplify regimen intensification.
Conclusions:
- Many fears surrounding insulin therapy in T2DM are unfounded.
- Current insulin options are simple, effective, and well-tolerated, reducing treatment burden.
- Optimized patient education and advanced insulin formulations facilitate successful T2DM management.
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...